21,24-Dioxa-2,15,18,27-tetraazanonacosan-29-oic acid,27-(carboxymethyl)-3,14,17-trioxo-16-[[(1-oxohexadecyl)amino]methyl]-1-(1-pyrenyl)- (494769-49-2)

Identification
Name:	21,24-Dioxa-2,15,18,27-tetraazanonacosan-29-oic acid,27-(carboxymethyl)-3,14,17-trioxo-16-[[(1-oxohexadecyl)amino]methyl]-1-(1-pyrenyl)-
CAS:	494769-49-2
Molecular Formula:	C₅₈H₈₇N₅O₁₀
Molecular Structure:
Properties
Safety Data

Other Product

1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
21,24-Dioxa-2,15,18,27,30,33,36-heptaazaoctatriacontan-38-oic acid,30,33,36-tris(carboxymethyl)-3,14,17,28-tetraoxo-16-[[(1-oxohexadecyl)amino]methyl]-1-(1-pyrenyl)-
1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
1/C30H52/c1-10-25(6)16-12-20-30(9,21-13-17-26(7)15-11-14-23(2)3)29-22-27(8)18-19-28(29)24(4)5/h10,17,22-23,25,28-29H,1,4,11-16,18-21H2,2-3,5-9H3/b26-17
1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
1/C23H22N2O2/c26-23(27-22-15-25-11-7-17(22)8-12-25)21-14-18(13-16-5-9-24-10-6-16)19-3-1-2-4-20(19)21/h1-6,9-10,13-14,17,22H,7-8,11-12,15H2/b18-13
21,24-Dioxa-2,15,18,27,30,33-hexaazapentatriacontan-35-oic acid,30,33-bis(2-ethoxy-2-oxoethyl)-3,14,17,28-tetraoxo-16-[[(1-oxohexadecyl)amino]methyl]-1-(1-pyrenyl)-, ethyl ester
29-Nordammara-13(17),24-dien-21-oic acid,3,11-dihydroxy-16-[(1-methylethyl)- thio]-,(3R,4R,8R,9â,11R,14â,16â,20ê)-
(2R,3R)-N-{(1'S,2S,7'R,9'Z,17'S,20'S,21'S,29'S,32'R)-29'-benzyl-32'-[(1R)-1-hydroxyethyl]-7',20',28'-trimethyl-24'-[(1S)-1-methylpropyl]-11',14',18',22',25',27',30',33'-octaoxospiro[oxirane-2,8'-[6,15,19]trioxa[12,23,26,28,31,34]hexaazatricyclo[15.9.8.2~2
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
1/C18H18O6/c1-22-14-8-13(20)15-16(21)11(9-24-18(15)17(14)23-2)7-10-3-5-12(19)6-4-10/h3-6,8,11,19-20H,7,9H2,1-2H
(4α,8α,9β,13α,14β,17Z)-16β-acetoxy-3α,11α-dihydroxy-29-nordammara-17(20),24-dien-21-oic acid, compound with 2,2'-iminodiethanol (1:1)
Spiro[cyclopentane-1,2'-[9,4](epoxypentadeca[1,11,13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)-1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'-methoxy-7',9',15',17',19',21',25'-heptamethyl-,[9'S-(9'R*,12'E,14'R*,15'S*,16'R*,17'S*,18'S*,19'S*,20'R*,21'R*,22'E,24'Z)]-(9CI)
Spiro[cyclohexane-1,2'-[9,4](epoxypentadeca[1,11,- 13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]- imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)- 1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'- methoxy-7',9',15',17',19',21',25'-heptamethyl-,(9'S,12'E,14'S,15'R,16'S,17'R,18'R,19'R,20'S,- 21'S,22'E,24'Z)-
29-Nordammara-17(20),24-dien-21-oic acid,16-(acetyloxy)-3-azido-11-hydroxy-,(3R,4R,8R,9â,11R,13R,14â,16â,17Z)-
1/C19H20O5/c1-11(2)7-18(21)24-19(3,4)16-9-13-8-12-5-6-17(20)23-14(12)10-15(13)22-16/h5-8,10,16H,9H2,1-4H